Feeding infants with CHD with breast milk: Norwegian Mother and Child Cohort Study

B S Tandberg1, E Ystrom, M E Vollrath

  • 1Division of Paediatrics, Nursing Profession Centre, Oslo University Hospital, Rikshospitalet, Norway. bente.silnes.tandberg@rikshospitalet.no

Insights

Mothers of infants with congenital heart defects (CHD) wean earlier, especially those with comorbidities. However, continued breastfeeding rates remain significant, highlighting the need for further research into supportive factors for these infants.

Area of Science:

  • Pediatrics
  • Cardiology
  • Public Health

Background:

  • Congenital heart defects (CHD) affect infant feeding practices.
  • Breast milk feeding (BMF) offers numerous benefits for infant health.
  • Understanding BMF in infants with CHD is crucial for optimizing care.

Purpose of the Study:

  • To determine the prevalence of BMF in infants with CHD during the first six months of life.
  • To compare BMF rates in infants with CHD to the general population.
  • To investigate the impact of comorbidities on BMF in infants with CHD.

Main Methods:

  • Utilized data from the Norwegian Mother and Child Cohort Study.
  • Included 131 infants with moderate/severe CHD and 65 with comorbidities.
  • Analyzed feeding status using Cox regression analyses.

Main Results:

  • Mothers of infants with CHD had a 1.69 HR of weaning compared to controls.
  • Mothers of infants with CHD and comorbidities had a 3.54 HR of weaning.
  • At 6 months, 9.9% of infants with CHD were predominantly breastfed, 64.1% continued, and 26% received none.

Conclusions:

  • CHD and comorbidities increase the risk of earlier weaning.
  • Continued breastfeeding rates are relatively high despite increased weaning risk.
  • Further research is needed to identify factors supporting BMF in infants with CHD.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...